Cargando…
Impact of Medication Discontinuation on Patients With Inflammatory Bowel Disease During the COVID-19 Outbreak
Autores principales: | Chen, Junrong, Peng, Xiang, Zhang, Min, Zhi, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834630/ https://www.ncbi.nlm.nih.gov/pubmed/32553758 http://dx.doi.org/10.1053/j.gastro.2020.05.087 |
Ejemplares similares
-
Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?
por: Hayashi, Yuki, et al.
Publicado: (2022) -
Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
por: Zingone, Fabiana, et al.
Publicado: (2020) -
COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China
por: Dai, Cong, et al.
Publicado: (2021) -
Urgent surgery for inflammatory bowel diseases during the COVID-19 outbreak in a high incidence area - Experience from a high-volume centre
por: Botti, Fiorenzo, et al.
Publicado: (2020) -
Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)